Neuren Pharmaceuticals Limited (ASX:NEU)

Australia · Delayed Price · Currency is AUD

20.64

+0.18 (0.88%)

Sep 8, 2026, 4:10 PM AEST

Neuren Pharmaceuticals Financials Overview

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	69.53	64.65	216.83	231.94	15.42	3.2
Revenue Growth	7.54%	-70.19%	-6.51%	1404.46%	382.23%	345.89%
Gross Profit	20.61	28.26	183.86	205.19	2.71	-6.32
Operating Income	13.86	22.04	179.16	199.25	-0.73	-8.23
Net Income	20.26	30.44	142.04	157.08	0.18	-7.79
Earnings Per Share	0.16	0.23	1.09	1.20	0.00	-0.07
EPS Growth	-33.00%	-78.57%	-9.58%	120020.00%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Commercial Products	69.51	64.63	213.24	231.93	14.55
Corporate	-	0.02	3.59	0.02	-
Total	69.53	64.65	216.83	231.94	14.55

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	286.54	296.12	222.24	228.54	40.18	36.78
Net Cash Growth	-3.23%	33.24%	-2.76%	468.79%	9.23%	52.07%
Net Cash Per Share	2.21	2.26	1.70	1.75	0.31	0.31
Cash & Investments	286.54	296.12	222.24	228.54	40.18	36.78

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5.12	125.42	-11.27	184.93	3.6	-9.97
Capital Expenditures	-0.04	-0.04	-0.01	-0.04	-0.02	-0.01
Free Cash Flow	5.08	125.39	-11.28	184.89	3.58	-9.98
Free Cash Flow Growth	-95.95%	-	-	5064.39%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	29.64%	43.71%	84.80%	88.47%	17.55%	-197.65%
Operating Margin	19.94%	34.09%	82.63%	85.90%	-4.75%	-257.52%
Pretax Margin	38.57%	60.22%	84.37%	88.44%	1.19%	-243.79%
Profit Margin	29.13%	47.08%	65.51%	67.72%	1.19%	-243.79%
FCF Margin	7.30%	193.95%	-5.20%	79.71%	23.22%	-312.17%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	131.22	77.43	11.18	20.23	5442.54	-
Forward PE	40.84	55.42	19.45	32.20	19.55	135.13
P/FCF Ratio	510.89	18.80	-	17.19	279.73	-
PS Ratio	37.31	36.46	7.32	13.70	64.96	148.54